Janus Henderson Group plc 13D and 13G filings for Olema Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-12 12:21 pm Sale |
2023-12-31 | 13G | Olema Pharmaceuticals, Inc. OLMA |
JANUS HENDERSON GROUP PLC JHG |
700,100 1.300% |
-2,357,206 (-77.10%) |
Filing |
| 2023-02-10 11:26 am Purchase |
2022-12-31 | 13G | Olema Pharmaceuticals, Inc. OLMA |
JANUS HENDERSON GROUP PLC JHG |
3,057,306 7.600% |
61,866 (+2.07%) |
Filing |
| 2022-02-10 4:49 pm Sale |
2021-12-31 | 13G | Olema Pharmaceuticals, Inc. OLMA |
JANUS HENDERSON GROUP PLC JHG |
2,995,440 7.400% |
-643,398 (-17.68%) |
Filing |
| 2021-02-12 3:42 pm Purchase |
2020-12-31 | 13G | Olema Pharmaceuticals, Inc. OLMA |
JANUS HENDERSON GROUP PLC JHG |
3,638,838 9.100% |
3,638,838 (New Position) |
Filing |